Nevada Board of Pharmacy issued notice proposing to add ethylphenidate and 2‑methyl AP‑237 to Schedule I (NAC 453.510) with hearing set for Dec 4, 2025

The Nevada State Board of Pharmacy published a public hearing notice and proposed regulation text to amend NAC 453.510 to add ethylphenidate and 2‑methyl AP‑237 to Schedule I under Nevada’s Uniform Controlled Substances Act implementation. The notice sets a public hearing for Dec. 4, 2025. (Note: a separate later Nevada Register informational statement indicates these substances were subsequently adopted into Schedule I; this record captures the earlier proposal and comment/hearing step.)